Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.
(01:14)
Could you give us a brief overview of this assay?
(02:06)
Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method?
(04:00)
When is this test typically ordered for transplant patients? Is it used throughout their treatment?
(06:56)
Could an immunocompromised person be unknowingly infected?
(07:31)
Is our quantitative method approved for pediatric patients?
(08:00)
How are the test results used to treat patients?
(10:36)
What other infections might providers consider alongside adeovirus?